| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JUNO | Juno Therapeutics, Inc. | Harr Steve | CFO & Head, Corp. Development | Mar 05, 2018 | Option Exercise | $87.00 | 542,365 | 47,185,755 | 147,162 | Mar 07, 2018, 06:20 PM | |
| JUNO | Juno Therapeutics, Inc. | Harr Steve | CFO & Head, Corp. Development | Feb 07, 2018 | Option Exercise | $85.49 | 1,704 | 145,675 | 790,763 | Feb 09, 2018, 07:32 PM | |
| JUNO | Juno Therapeutics, Inc. | Harr Steve | CFO & Head, Corp. Development | Dec 21, 2017 | Sale | $26.74 | 17,500 | 467,974 | 772,082 | Dec 22, 2017, 04:59 PM | |
| JUNO | Juno Therapeutics, Inc. | Harr Steve | CFO & Head, Corp. Development | Jul 03, 2017 | Option Exercise | $19.36 | 17,500 | 338,800 | 736,189 | Jul 05, 2017, 06:41 PM | |
| JUNO | Juno Therapeutics, Inc. | Harr Steve | CFO & Head, Corp. Development | Jun 27, 2017 | Option Exercise | $19.36 | 17,500 | 338,801 | 736,189 | Jun 29, 2017, 07:43 PM | |
| JUNO | Juno Therapeutics, Inc. | Harr Steve | CFO & Head, Corp. Development | Jun 10, 2016 | Sale | $43.32 | 30,000 | 1,299,530 | 716,052 | Jun 13, 2016, 07:20 AM | |
| JUNO | Juno Therapeutics, Inc. | Harr Steve | See Remarks | Mar 04, 2016 | Sale | $45.00 | 5,000 | 225,000 | 730,000 | Mar 04, 2016, 09:00 PM | |
| JUNO | Juno Therapeutics, Inc. | Harr Steve | See Remarks | Mar 01, 2016 | Sale | $37.58 | 30,000 | 1,127,342 | 762,987 | Mar 02, 2016, 09:03 PM | |
| JUNO | Juno Therapeutics, Inc. | Harr Steve | See Remarks | Dec 10, 2015 | Sale | $46.43 | 35,000 | 1,625,074 | 768,600 | Dec 11, 2015, 09:00 PM |
Menu